Free Trial
OTCMKTS:EXDI

Exactus (EXDI) Stock Price, News & Analysis

Exactus logo

About Exactus Stock (OTCMKTS:EXDI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
257,300 shs
Average Volume
83,144 shs
Market Capitalization
$38.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EXDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.

EXDI Stock News Headlines

Ish Msci France Regulatory News
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Starbreeze AB B (STZEb)
Exactus, Inc. to Present at BIO CEO & Investor Conference
See More Headlines

EXDI Stock Analysis - Frequently Asked Questions

Exactus's stock reverse split on Thursday, October 28th 2021.The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactus investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and Aytu BioPharma (AYTU).

Company Calendar

Today
8/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EXDI
CIK
1552189
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.46 million
Net Margins
N/A
Pretax Margin
-15,131.74%
Return on Equity
-3,272.69%
Return on Assets
-185.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.32
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$2.07 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
599,005,000
Free Float
209,652,000
Market Cap
$38.94 million
Optionable
Not Optionable
Beta
4.21

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:EXDI) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners